Valye reports for unlimited access

Amplify Commodity Trust operates as a Delaware statutory trust offering commodity ETFs, including BDRY, which provides exposure to dry bulk shipping freight futures. BDRY's investment strategy involves holding a benchmark portfolio of exchange-cleared futures contracts on dry bulk freight, specifically Capesize, Panamax, and Supramax categories. The benchmark portfolio is maintained and rebalanced annually by Breakwave Advisors LLC, the Trust's Commodity Trading Advisor. BDRY invests substantially all assets in these futures contracts, maintaining long-only positions and rolling contracts quarterly to maintain exposure. The Trust holds cash and cash equivalents for liquidity and margin requirements. The Trust's operations, management, and marketing are handled by Amplify Investments LLC, the Sponsor, with administrative and custodial services provided by U.S. Bank and affiliates. BDRY trades on NYSE Arca under the symbol 'BDRY' since March 2018.

SunHydrogen, Inc. focuses on developing renewable hydrogen production technology using photoelectrochemical panels that split water into hydrogen and oxygen using sunlight without external electrical bias. The company pursues two main technology pathways: a thin film approach leveraging re-engineered commercial solar modules, and a nanoparticle approach using patented photoelectrosynthetically active heterostructures. It has built and installed pilot hydrogen reactors at the University of Texas at Austin and collaborates with industrial partners including CTF Solar GmbH and Honda R&D Co., Ltd. SunHydrogen aims to produce hydrogen at a cost competitive with natural gas-derived hydrogen, though current techno-economic models indicate higher costs. The company holds issued patents and pending applications covering its core technologies and manufacturing methods. It operates subsidiaries in Austria and Japan to identify market opportunities and potential customers. Financially, SunHydrogen reported limited revenue and a net loss for the fiscal year ending June 30, 2026, with strong liquidity and no material legal proceedings.

Lakeside Holding Ltd is a holding company with three principal business areas: pharmaceutical distribution through its subsidiary Hupan Pharmaceutical, quantum-related technology initiatives via Quantum Nexus, and AI compute capacity and managed inference services through XDT Infrastructure I, LLC. The pharmaceutical distribution business operates in the midstream segment of the pharmaceutical supply chain in China, sourcing products from manufacturers and distributing to hospitals and healthcare providers. The company ceased its cross-border supply chain business in early 2026. Quantum Nexus and AI compute services are in early stages without revenue generation. The company is subject to regulatory and operational risks associated with its PRC operations and foreign exchange controls.

GenFlat Holdings, Inc. operates in the intermodal transportation equipment industry, specializing in patented collapsible marine containers that reduce repositioning costs, storage space, and carbon emissions. The company manufactures containers in China and sells and leases them primarily to shipping lines and logistics companies. Commercial operations started in 2024, with initial lease agreements and trials in place. The company’s containers meet international standards and offer significant operational efficiencies compared to conventional containers. GenFlat’s business model includes equipment leasing and sales, supported by a marketing strategy targeting container shipping companies, logistics firms, and the U.S. military. The company reported limited revenue and a net loss for the fiscal year ended June 30, 2026, with a qualified sales pipeline of approximately $400 million in potential contract value [S1].

NioCorp Developments Ltd is a mining development company listed on Nasdaq (ticker: NB) and the Frankfurt Stock Exchange (ticker: BR30). The company is advancing the Elk Creek Project, a critical minerals mine, and has completed significant exploration and feasibility studies including the 2025 Drilling Program and the 2026 Elk Creek Study. As of June 30, 2026, NioCorp held $415 million in cash and equivalents and had a strong liquidity position with a current ratio above 25. The company reported a net loss of $48.6 million for fiscal year 2026, driven by increased exploration and administrative expenses. NioCorp has no revenues from mining operations to date and is focused on securing project financing to support construction commencement. The company has no long-term debt and has not paid dividends since inception. Risk factors disclosed include mining, regulatory, debt, and equity-related risks [S1].

SR Bancorp, Inc. is the holding company for Somerset Regal Bank, which operates 14 branches across six counties in northern and central New Jersey. The bank was formed in 2023 through the merger of Somerset Bank and Regal Bank, combining residential and commercial lending expertise. The company completed a mutual-to-stock conversion in 2023, issuing shares to the public and its Employee Stock Ownership Plan. The bank's market area includes diverse and affluent counties with a mix of urban and suburban customers. The loan portfolio is balanced between residential mortgages (52.6%) and commercial loans (45.7%), including multi-family and commercial real estate. The company faces competition from larger banks, credit unions, mortgage companies, and fintech firms. Financially, as of June 30, 2026, the company held $71.5 million in cash and cash equivalents, with net income of $3.35 million for the fiscal year and EPS of $0.45 basic. Recent developments include equity plan approval, stock repurchase authorization, and insider buying activity.

Critical Metals Corp. is a foreign private issuer focused on rare earth metals exploration and development, with a flagship project named Tanbreez located in Greenland. The company is actively expanding its operations through strategic acquisitions and partnerships, including a binding agreement to acquire European Lithium Ltd. and a joint venture for a rare earth processing facility with a major Saudi Arabian industrial conglomerate. These initiatives aim to establish a vertically integrated supply chain from mining to processing, targeting defense industry applications in the United States and Saudi Arabia. The company has reported significant drilling results and is deploying advanced technologies such as autonomous communications and drone systems to support project development.

CID Holdco, Inc. develops and offers a SaaS platform for real-time tracking and management of high-value assets using advanced technologies including passive and active RFID, AI-enabled edge cameras, and machine learning algorithms. The platform provides customers with enhanced safety, security, and operational efficiency by enabling precise location tracking and intelligent workflow management. The company serves multiple verticals such as construction, military, mining, retail, warehousing, manufacturing, aviation ground support, medical logistics, and yard management. CID Holdco operates manufacturing through its subsidiary Dot Works in Puerto Rico and has development teams in the United States and India. The company integrates its solutions with enterprise software systems to provide edge intelligence and data for supervisory systems. Revenue is concentrated among a few customers, and the company is actively developing new software modules and commercialization activities. CID Holdco faces competition from a fragmented market with various specialized vendors [S1][S2].

Scholastic Corporation is a diversified publishing and education company with operations spanning children's book publishing and distribution, education solutions, entertainment, and international markets. The company’s business model includes segments such as Book Clubs, Book Fairs, Trade US and International, Education, and Entertainment. Scholastic manages a broad portfolio of assets including property, plant and equipment, prepublication costs, and investments in film and television programs. The company maintains a capital structure with both short-term and long-term liabilities, including operating lease obligations and long-term debt. Recent quarterly financial results show a decline in revenues and a net loss, reflecting ongoing challenges in the operating environment. Scholastic actively engages with investors through earnings calls and detailed financial disclosures [S1][S2].

Woodbridge Liquidation Trust was established pursuant to a bankruptcy plan to hold and liquidate assets formerly owned by multiple Debtors. The Trust's primary function is to receive cash remittances from its Wind-Down Entity and subsidiaries, resolve disputed claims, prosecute causes of action, pay administrative and priority claims, and distribute cash to Interestholders according to a defined waterfall. The Trust is governed by a Liquidation Trustee and Supervisory Board and operates under Delaware statutory trust law. Allowed claims are categorized into Standard Note Claims, General Unsecured Claims, and Unit Claims, which convert into Class A and Class B Liquidation Trust Interests. The Trust's assets include cash, restricted cash, and other miscellaneous assets, with liabilities including accounts payable and accrued liquidation costs. Distributions to Interestholders have been made periodically but were suspended in August 2023 due to pending litigation related to a construction defect claim [S1][S2].

Home Federal Bancorp Inc of Louisiana is a Louisiana-chartered holding company for Home Federal Bank, a federally chartered stock savings bank established in 1924. The bank operates primarily in northwest Louisiana, serving the Shreveport-Bossier City-Minden combined statistical area through its home office and ten full-service branches. The company’s business model centers on attracting deposits from the public and using those funds to originate loans, with a focus on one-to-four family residential loans, commercial real estate, and other real estate-related lending. The bank also sells a portion of its fixed-rate conforming residential loans to correspondent banks to manage interest rate risk. The company’s loan portfolio as of June 30, 2026, totaled approximately $475.5 million, diversified across various loan types. The company declared quarterly cash dividends of $0.135 per share in early 2026 and announced leadership changes during the year. Financial disclosures include net income of $6.174 million and EPS of $2.05 for the fiscal year ended June 30, 2026.

Cannabis Suisse Corp. is a company with limited current operations, mainly subleasing part of a building it leases from an entity controlled by its CEO. The company has no employees and relies on its CEO, who also serves as CFO on a part-time basis, to manage operations. It holds majority voting control through its CEO, who also holds convertible promissory notes convertible into a large number of shares. The company has reported no revenue for the fiscal year ended May 31, 2026, but recorded net income of $122,739. Cannabis Suisse Corp. is engaged in the development and marketing of CBD products under its Swiss4Life brand, including pre-rolled cannabis joints and cannabis oils. It has also announced the development of an AI-based IT product called 'Cannabis Life'. The company faces significant liquidity constraints, with a current ratio of 0.09 and a going concern opinion in its latest audited financial statements. Its shares are classified as penny stocks, which may limit liquidity and trading activity.

Marine Petroleum Trust is a royalty trust that distributes income primarily through dividends to its unitholders. The trust does not have directors or officers, and its operations are managed by a trustee, Argent Trust Company, as per SEC filings. The trust regularly declares dividends and schedules ex-dividend dates, which are publicly reported by financial news outlets. Detailed financial metrics and comprehensive business model disclosures are not provided in the available SEC excerpts or recent news.

Donaldson Company, Inc., founded in 1915, specializes in technology-driven filtration products and solutions serving a broad range of industries globally. The company operates through three main segments: Mobile Solutions, Industrial Solutions, and Life Sciences, each offering diverse filtration products tailored to specific markets such as construction, mining, aerospace, bioprocessing, and microelectronics. With over 150 locations worldwide, including manufacturing and distribution centers, Donaldson emphasizes innovation, customer service, and strategic acquisitions to enhance its market presence. The recent acquisition of Facet Filtration expands its footprint in aerospace and power generation filtration markets. The company manages raw material costs through supply agreements and pricing strategies and reports a healthy backlog and seasonal earnings patterns.

Cracker Barrel Old Country Store, Inc. is a U.S.-based restaurant and retail company operating a network of over 650 stores, combining dining and retail experiences. The company owns and leases a substantial portfolio of properties across many states, with headquarters and distribution centers in Tennessee. It has a seasoned executive team with deep experience in the restaurant and retail sectors. The company’s financial disclosures indicate moderate liquidity constraints with a current ratio below 1. It reported positive net income and earnings per share for the fiscal year ending July 2026. The company actively manages cybersecurity risks through a structured program aligned with recognized frameworks and maintains cyber insurance. Recent earnings calls and news coverage reflect ongoing operational performance and strategic focus on improving profitability and revenue.

Incannex Healthcare Inc. operates as a clinical-stage biopharmaceutical company developing novel oral fixed-dose combination therapies and psychedelic-assisted treatments targeting serious chronic conditions with unmet medical needs. The company’s lead development program is IHL-42X, an oral combination of dronabinol and acetazolamide for obstructive sleep apnea (OSA). IHL-42X completed Phase 2 clinical trials demonstrating significant reductions in apnea hypopnea index and improvements in patient-reported outcomes, leading to FDA Fast Track designation. A Phase 2 dose confirmation study (DReAMzz) is underway to optimize dosing prior to a planned Phase 3 trial. Another lead candidate, PSX-001, is a synthetic psilocybin treatment combined with psychological therapy for generalized anxiety disorder (GAD), with positive Phase 2 results and ongoing development planning. The company also developed IHL-675A, targeting inflammatory conditions such as rheumatoid arthritis, but its Phase 2 trial was terminated due to recruitment challenges. Incannex pursues regulatory pathways including FDA expedited programs and 505(b)(2) to facilitate approval. The company maintains a global intellectual property strategy and focuses capital and resources primarily on IHL-42X and PSX-001. Financially, as of June 30, 2026, the company reported strong liquidity with $67.7 million in cash and equivalents and a current ratio of 48.81, alongside a net loss of $19.3 million for fiscal 2026.

Astrotech Corporation is focused on commercializing its proprietary Astrotech Mass Spectrometer Technology™ (AMS Technology) platform through application-specific wholly owned subsidiaries. The AMS Technology is designed to be smaller, less expensive, and easier to use than traditional mass spectrometers, operating under ultra-high vacuum to improve detection accuracy and reduce false alarms. The company’s subsidiaries include 1st Detect Corporation, which develops explosives and narcotics trace detectors such as the TRACER 1000™ certified by European and U.S. authorities; AgLAB Inc., which targets the hemp and cannabis market with mass spectrometry solutions to optimize distillation yields; BreathTech Corporation, focused on breath analysis for volatile organic compounds; Pro-Control Inc., which applies AMS Technology to industrial process control; EN-SCAN Inc., which develops portable environmental testing instruments; and Lunar Power and Light Corporation, an early-stage initiative exploring lunar resource and infrastructure development. Astrotech’s products are deployed in security, agriculture, industrial, environmental, and emerging lunar technology markets. The company holds multiple patents and licenses its technology exclusively to its subsidiaries. As of mid-2026, the company maintains strong liquidity but continues to report net losses and requires additional capital to support ongoing operations and development.

Ferrellgas Partners L P operates as a holding entity primarily owning interests in its operating partnership and finance subsidiary. It relies on cash distributions from its operating partnership to meet financial obligations and pay distributions to unitholders. The company carries substantial debt with associated restrictive covenants and preferred units that influence its financial flexibility and governance. Its Class A Units trade on OTC markets, which may limit liquidity and market pricing. The company faces regulatory compliance risks including environmental, health and safety laws, data privacy legislation, and intellectual property rights issues.

Tamboran Resources Corp operates in the oil and gas exploration and production sector. The company is currently undergoing a significant business combination through the acquisition of Falcon Entities, which will result in a combined company with shared ownership between existing Tamboran and Falcon shareholders. The acquisition is complex and involves regulatory, legal, and operational risks. Tamboran maintains a strong liquidity position as of June 30, 2026, with cash and current assets exceeding current liabilities. The company reported no revenue and a net loss for the fiscal year ended June 30, 2026. Recent leadership changes include the appointment of Todd Abbott as CEO in early 2026. The company has received analyst coverage with positive recommendations and has experienced insider buying activity.

BlackBerry Ltd is a technology company specializing in secure, reliable software for embedded systems and secure communications. Founded in 1984 and headquartered in Waterloo, Ontario, it serves automotive OEMs, governments, and regulated industries. The company operates through three divisions: QNX, Secure Communications, and Licensing. QNX provides real-time operating systems and related software for automotive and industrial embedded applications. Secure Communications offers encrypted voice, messaging, unified endpoint management, and crisis communications solutions. The Licensing division manages a large patent portfolio generating revenue through licensing and enforcement. BlackBerry employs a mix of perpetual and subscription licensing models and targets regulated and adjacent industries with high-performance software needs.

H.B. Fuller Company, founded in 1887 and incorporated in Minnesota in 1915, is a leading global formulator, manufacturer, and marketer of adhesives, sealants, and specialty chemical products. The company operates in 34 countries with manufacturing and sales facilities worldwide. Its product portfolio serves a broad range of industries including consumer goods, construction, automotive, aerospace, and electronics. The company reorganized its operating segments in fiscal 2025 to better align with its business strategy, forming the Building Adhesive Solutions segment among others. H.B. Fuller emphasizes research and development to innovate adhesive technologies and support sustainability initiatives. The company maintains compliance with environmental, safety, anti-corruption, and data protection regulations. It has approximately 7,100 employees globally and a diverse customer base with no single customer exceeding 10% of consolidated revenue [S1].

Rezolute, Inc. focuses on developing therapies for rare and debilitating hypoglycemia caused by various forms of hyperinsulinism. Its lead product candidate, ersodetug, is a human monoclonal antibody designed to down modulate insulin receptor activity, thereby normalizing glucose levels. The company is advancing ersodetug through late-stage clinical trials, including the sunRIZE Phase 3 study for congenital HI and the upLIFT Phase 3 study for Tumor HI. Despite the sunRIZE study not meeting its primary and key secondary endpoints, data showed clinically relevant improvements in continuous glucose monitoring metrics. Rezolute has engaged with the FDA under Breakthrough Therapy Designation to discuss regulatory pathways and is preparing comprehensive datasets for further evaluation. The company maintains a strong liquidity position with significant cash and short-term investments as of June 30, 2026, supporting ongoing clinical development activities.

Legacy Education Inc. provides career-focused post-secondary education services through four accredited institutions: High Desert Medical College, Central Coast College, Integrity College of Health, and Contra Costa Medical Career College. These institutions offer a variety of healthcare and allied health programs including nursing, ultrasound technician, medical assisting, dental assisting, pharmacy technician, and others. The company primarily operates in California with plans to expand geographically, including a new campus planned in Houston, Texas. Legacy Education emphasizes student and graduate success, affordable degrees with high return on investment, and relationship-based marketing to drive enrollment. The company has a history of acquisitions and program expansions, and it operates in a competitive and fragmented post-secondary education market. It relies on federal student financial assistance programs and is subject to regulatory and accreditation requirements. As of June 30, 2026, the company reported net income of $9.1 million and maintains strong liquidity ratios [S1].

Stitch Fix, Inc. is an online personal styling service operating primarily in the United States. The company offers personalized apparel, shoes, and accessories through two main client engagement models: 'Fixes,' which are curated shipments combining AI-driven recommendations and human Stylist selections, and 'Freestyle,' which allows clients to purchase directly from curated assortments online. Clients provide detailed style, fit, and budget preferences via onboarding quizzes and ongoing feedback, which feed proprietary algorithms to enhance personalization. Stitch Fix sources merchandise from brand partners and its Owned Private Label Brands, with manufacturing primarily outsourced to third-party vendors. The company operates three U.S. fulfillment centers leveraging AI to optimize inventory allocation, shipping, and returns. As of August 1, 2026, Stitch Fix had approximately 2.28 million active clients and has delivered over 100 million Fixes since inception. The business model emphasizes client relationships, data science, and AI to differentiate in a competitive retail apparel market.

Manchester United plc is a publicly traded company known primarily for its association with the Manchester United football club. The company reports financial results in GBP and has disclosed recent financial data through SEC filings. As of the end of 2025, the company showed modest net income but faces liquidity challenges given its low current and cash ratios. Recent news coverage highlights fluctuations in profitability and stock performance, reflecting operational and market dynamics.

Shuttle Pharmaceuticals Holdings, Inc. is a pharmaceutical company that has recently shifted its strategic focus towards AI-driven drug discovery. This shift follows the acquisition of Molecule.ai, a platform that uses artificial intelligence to accelerate molecular discovery and early-stage drug development. The company has wound down its clinical trials of its lead product candidate Ropidoxuridine but continues to report progress on Phase 2 clinical trials for Glioblastoma. Shuttle Pharmaceuticals has also expanded into the cryptocurrency mining sector through the acquisition of United Dogecoin, an early-stage company with limited operating history and significant operational risks. The company has raised capital through multiple equity offerings to support its growth initiatives and clinical trials. Financially, the company reported a net loss and working capital deficit as of mid-2026, with liquidity ratios reflecting financial constraints. Shuttle Pharmaceuticals is listed on Nasdaq and has taken measures to maintain compliance with listing standards.

TRIO-TECH INTERNATIONAL is a semiconductor industry company specializing in manufacturing test equipment, providing testing services, and distributing semiconductor and electronic components. Its product portfolio includes equipment for front-end and back-end semiconductor manufacturing processes, such as leak detectors, autoclaves, centrifuges, burn-in systems, HAST testers, and temperature-controlled chucks. The company also offers customized solutions and supports customer R&D efforts. The business is segmented into Semiconductor Back-end Solutions and Industrial Electronics, which together accounted for nearly all revenue in fiscal 2026. The company operates globally with significant operations in Malaysia, Singapore, and China [S1].

RAVE RESTAURANT GROUP, INC. franchises and licenses pizza restaurant concepts primarily under the Pizza Inn and Pie Five brands. Pizza Inn includes Buffet Units, Delco Units (delivery/carryout), Express Units, and ghost kitchens, while Pie Five focuses on fast casual individualized pizzas. The company operates through a franchise model, with franchisees required to adhere to operational standards and contribute to marketing funds. As of June 28, 2026, the company had 109 Pizza Inn franchised restaurants (mostly domestic) and 13 Pie Five franchised units. The company supports franchisees with training, quality control, and supply chain management through authorized distributors. The company reported net income of $2.878 million and EPS of $0.20 for fiscal 2026, with strong liquidity and cash positions. The restaurant industry is highly competitive, with many larger and more established competitors.

Campbell's Co operates as a manufacturer and marketer of high-quality branded food and beverage products with a long heritage. The company focuses on everyday cooking and snacking categories in the U.S. and manages a portfolio of brands including soups, pasta sauces, snacks, and beverages. It pursues growth through consumer insights, innovation, and enterprise-wide transformation initiatives aimed at improving commercial capabilities, digital advancement, and cost efficiencies. The company has made strategic acquisitions such as Sovos Brands and a significant stake in La Regina, while divesting non-core businesses like noosa yoghurt and Pop Secret popcorn. Campbell's operates in a competitive environment with evolving consumer preferences, retail dynamics, and regulatory scrutiny. It faces commodity cost inflation, tariffs, and supply chain challenges that impact margins and volumes. The company implements cost savings and optimization initiatives to mitigate these pressures and enhance profitability.

Immuron Ltd operates as a commercial and clinical-stage biopharmaceutical company with a proprietary platform technology based on oral polyclonal immunoglobulins derived from hyper-immune bovine colostrum. The company develops and commercializes products targeting inflammatory and infectious diseases, focusing on gastrointestinal tract delivery. Its flagship products include Travelan®, an over-the-counter treatment to reduce travelers' diarrhea risk, and ProIBS®, a medical device for IBS symptom relief. Immuron has two lead clinical-stage drug candidates targeting Enterotoxigenic Escherichia coli infections and Clostridioides difficile infections. The company collaborates with the U.S. Department of Defense on clinical trials and research. Immuron's sales have shown consistent growth, with AUD 7.7 million in fiscal 2026. The company maintains a strong intellectual property portfolio protecting its biologics and technology platform [S1][N1][N2][N3].

AtlasClear Holdings, Inc. is a fintech-driven business-to-business platform focused on providing a modern, integrated suite of financial services including trading, clearing, settlement, custody, and banking. The company targets financial services firms such as brokerages, hedge funds, pension plans, and family offices with annual revenues up to $1 billion, a segment underserved by larger clearing firms due to high minimums and lack of transparency. Through acquisitions of Wilson-Davis (now AtlasClearing), Quantum FinTech Acquisition Corporation, and agreements to acquire Commercial Bancorp and Ark Financial Services, AtlasClear aims to offer specialized clearing and banking services with an emphasis on global markets. The company’s technology platform is designed to be flexible, scalable, and modern, automating back and middle office processes and providing APIs for trading, lending, portfolio management, account onboarding, cash management, transfers, regulatory compliance, and communications. Revenue is generated from transactional fees and recurring fees tied to customer accounts. The leadership team has extensive experience in financial technology and operations. The company reported $20.1 million in revenue and $1.96 million in net income for the fiscal year ended June 30, 2026, with liquidity ratios indicating a current ratio of 1.5 and cash ratio of 0.52.

Key Tronic Corp is a publicly traded company with recent financial disclosures indicating operational challenges and restructuring efforts. The company reported a significant net loss for fiscal year 2026 and has experienced revenue declines and widening losses in recent quarters. Despite these challenges, Key Tronic has undertaken operational restructuring and expanded manufacturing capacity in the US and Vietnam. Liquidity ratios as of June 27, 2026, show a current ratio of 2.1, indicating the company maintains sufficient current assets relative to current liabilities, though cash on hand is limited.

Nexscient, Inc. operates in the AI technology sector with a focus on acquiring and developing AI-driven technologies. The company has actively pursued acquisitions, including Flipside AI, which specializes in physical AI data capabilities, and a generative AI software application. It also formed a strategic alliance with Tekcapital to accelerate technology acquisitions. Nexscient launched NXNT Labs as part of its internal development efforts. Financially, as of June 30, 2026, the company reported revenues of approximately $1.1 million but incurred a net loss, with liquidity ratios indicating current liabilities exceed current assets.

21Shares Hyperliquid ETF is a Delaware statutory trust operating as an ETF listed on Nasdaq under the ticker THYP. The Trust's investment objective is to track the performance of the HYPE token, as measured by the FTSE Hyperliquid Index, adjusted for expenses and liabilities, and to reflect staking rewards from a portion of the Trust's HYPE holdings. The Trust holds its HYPE tokens with custodians Anchorage Digital Bank N.A. and BitGo Bank & Trust, N.A. The Trust commenced operations in May 2026 and is managed by 21Shares US LLC, a subsidiary of 21co Holdings Limited, ultimately owned by FalconX Holdings Limited. The Trust is classified as an investment company for accounting purposes and follows US GAAP. It is an emerging growth company and may comply with reduced reporting requirements. The Trust does not have directors or executive officers and reported net assets of approximately $71.2 million as of June 30, 2026.

Amesite Inc. develops AI-powered software solutions targeting the post-acute healthcare market and professionals. Its primary offerings are NurseMagic™, a documentation and workflow tool for nurses and healthcare enterprises, and LynkMagic™, an enterprise AI solution for healthcare organizations. The company emphasizes rapid deployment, regulatory compliance, and user-driven product development. It operates a freemium model for individual users and scalable subscription tiers for enterprises. Amesite holds multiple patents and trademarks protecting its technology and brand. The company maintains a small team and focuses on disciplined fiscal management while expanding product adoption and market reach.

NeoVolta Inc. is an energy technology company specializing in scalable energy storage solutions for residential, commercial & industrial, and utility-scale markets. Founded in 2018, the company initially focused on manufacturing high-performance energy storage systems (ESS) for residential and small commercial applications. Its product portfolio includes lithium iron phosphate battery systems such as the NV14, NV24, NVPlus, and NV7600 inverter, as well as larger commercial and industrial systems. NeoVolta markets primarily through certified solar installers and distributors, with geographic expansion beyond Southern California into states like Texas. The company is developing next-generation products like the NVWAVE modular battery platform, acquired through its 2025 acquisition of Neubau Energy's assets. In 2026, NeoVolta formed a joint venture to build a utility-scale battery manufacturing facility in Georgia, designed for scalable production capacity. The company competes with established ESS providers and differentiates through rapid product availability, installer support, product safety certifications, and a focus on underserved installer markets. NeoVolta holds multiple patents and invests in ongoing product development. It operates in a dynamic regulatory environment with evolving safety and tax credit standards. Financially, NeoVolta has increased revenues but continues to operate at a net loss, funding growth through equity offerings and joint venture capital contributions [S1][S2].